ORI Healthcare Fund L.P. (ORI Fund) announces the completion of US$18 million investment into Pillar Biosciences Inc., a Boston-based start-up specialized in next generation sequencing (“NGS”)-based ...
LONDON, April 14, 2020 /PRNewswire/ -- Today Ori Biotech Ltd (Ori), an innovator in cell and gene therapy (CGT) manufacturing, announced a partnership with Achilles Therapeutics (Achilles) to test the ...
A leading developer of cloud-based decentralized manufacturing for cell therapies has announced a partnership to test their technology platform’s readiness for market. The partnership, between Ori ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results